Glatiramer Acetate 40 mg/mL in Relapsing–Remitting Multiple Sclerosis: A Review
Glatiramer Acetate 40 mg/mL in Relapsing–Remitting Multiple Sclerosis: A Review
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Glatiramer acetate (Copaxone
®
) is a synthetic analogue of myelin basic protein, which is thought to be involved in the pathogenesis of multiple sclerosis (MS). The therapeutic effects of the drug in the treatment of MS are thought to be via immunomodulation and neuroprotection. Subcutaneous glatiramer acetate 20 mg/mL once daily is approved...
Alternative Titles
Full title
Glatiramer Acetate 40 mg/mL in Relapsing–Remitting Multiple Sclerosis: A Review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1701477777
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1701477777
Other Identifiers
ISSN
1172-7047
E-ISSN
1179-1934
DOI
10.1007/s40263-015-0245-z
